← Open Payments lookup

ASHWINI NEELGUND: Open Payments

NPI 1487869574 · MATAWAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,760 in 92 payments from 19 companies in 2025. Trend: 2023 $987 · 2024 $1,388 · 2025 $1,760

Food & beverage: $1,760
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)14$317
ABBVIE INC.22$253
E.R. Squibb & Sons, L.L.C.8$245
Alkermes, Inc.9$160
Neos Therapeutics, LP7$141
Neurocrine BioSciences, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.6$97
Otsuka America Pharmaceutical, Inc.5$87
Bausch Health US, LLC4$69
Abbott Laboratories3$68

Products named: CAPLYTA, VRAYLAR, COBENFY, Adzenys XR-ODT, INGREZZA, LYBALVI, REXULTI, TRINTELLIX.

Industry payments across NJ — which companies pay providers there.